TLR3 and COVID-19: The other TLR3 agonist used in combination is the dsRNA hairpin that is formulated with Ad5 viral vector for use in an oral norovirus (NCT05626803) and oral COVID‐19 (NCT05067933) vaccine both developed by Vaxart.